| Source Date | Board Meeting Date | Details |
|
20-Feb-2025
|
25-Feb-2025
|
Quarterly Results
|
|
12-Aug-2024
|
14-Aug-2024
|
Quarterly Results
|
|
18-Jul-2024
|
23-Jul-2024
|
Inter alia, to consider and approve:- (1) to consider and approve raising fresh capital through issue of eligible securities to qualified institutional buyers by way of qualified institutional placement under the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 and any other methods including by way of further issue, in accordance with the relevant provisions of applicable laws and subject to approval of the shareholders of the Company and other applicable regulatory and contractual approvals, as may be required.
|
|
09-Jul-2024
|
15-Jul-2024
|
Audited Results & Quarterly Results
|
|
07-Dec-2023
|
11-Dec-2023
|
Quarterly Results (Revised) & Preferential Issue of shares (Revised) Inter-alia, to consider various options for raising fresh capital through issue of equity shares and/or convertible securities on preferential basis, in accordance with the relevant provisions of applicable laws and subject to approval of the shareholders of the Company and receipt of applicable regulatory approvals, as may be required.
|
|
04-Dec-2023
|
08-Dec-2023
|
Quarterly Results
|
|
07-Aug-2023
|
11-Aug-2023
|
Quarterly Results & Audited Results
|
|
10-Jul-2023
|
12-Jul-2023
|
Preferential Issue of shares
|
|
24-Feb-2023
|
27-Feb-2023
|
Scrip code : 500285 Name : SpiceJet Limited Subject : Board Meeting Intimation for Notice Of Adjournment Of Board Meeting Scheduled On February 24, 2023 SPICEJET LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/02/2023 ,inter alia, to consider and approve (a) issuance of equity shares on preferential basis consequent upon conversion of outstanding liabilities into equity shares of the Company, subject to applicable regulatory approvals. (b) raising fresh capital through issue of eligible securities to qualified institutional buyers, subject to applicable regulatory approvals. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Companys Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in securities of the Company shall remain closed for the Designated Persons till March 1, 2023 (end of the day).
|
|
14-Feb-2023
|
24-Feb-2023
|
Preferential Issue of shares (Revised) & Quarterly Results The Board of Directors of the Company in its meeting scheduled to be held on February 24, 2023 (Friday), will discuss and consider, inter-alia, issuance of equity shares on preferential basis consequent upon conversion of outstanding liabilities into equity shares of the Company, subject to applicable regulatory approvals. Further, the Board of Directors will also discuss and consider options for raising fresh capital through issue of eligible securities to qualified institutional buyers, subject to applicable regulatory approvals
|
|
08-Feb-2023
|
14-Feb-2023
|
Quarterly Results
|
|
09-Nov-2022
|
14-Nov-2022
|
Quarterly Results
|
|
23-Aug-2022
|
31-Aug-2022
|
Quarterly Results
|
|
23-May-2022
|
30-May-2022
|
Audited Results(Cancelled) (Cancelled)
|
|
14-Feb-2022
|
15-Feb-2022
|
SPICEJET LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/02/2022 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results for the third quarter ended December 31, 2021. Please find attached (a) notice for adjournment of Board Meeting of the Company originally scheduled to be held on February 14, 2022; and(2) update on closure of Trading Window in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015
|
|
08-Feb-2022
|
14-Feb-2022
|
Quarterly Results
|
|
08-Nov-2021
|
12-Nov-2021
|
Quarterly Results
|
|
09-Aug-2021
|
13-Aug-2021
|
Quarterly Results
|
|
24-Jun-2021
|
30-Jun-2021
|
Audited Results Inter-alia, options for raising fresh capital through issue of equity shares/debt instrument on preferential/qualified institutions placement basis, in accordance with the relevant provisions of applicable law and subject to approval of the shareholders of the Company and receipt of applicable regulatory approvals, as may be required.
|
|
04-Feb-2021
|
10-Feb-2021
|
Quarterly Results
|